525
Views
14
CrossRef citations to date
0
Altmetric
Review

Safety of available and emerging drug therapies for hyperhidrosis

&
Pages 1039-1049 | Received 20 Apr 2017, Accepted 10 Jul 2017, Published online: 16 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anna Campanati, Stamatis Gregoriou, Adamantia Milia-Argyti, George Kontochristopoulos, Giulia Radi, Federico Diotallevi, Emanuela Martina & Annamaria Offidani. (2022) The pharmacological treatment and management of hyperhidrosis. Expert Opinion on Pharmacotherapy 23:10, pages 1217-1231.
Read now
Stamatios Gregoriou, Polytimi Sidiropoulou, Georgios Kontochristopoulos & Dimitrios Rigopoulos. (2019) Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions. Clinical, Cosmetic and Investigational Dermatology 12, pages 733-744.
Read now

Articles from other publishers (12)

Tomoko Fujimoto, Takaaki Terahara, Koji Okawa, Hiroshi Inakura, Yuta Hirayama & Hiroo Yokozeki. (2023) Long‐term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open‐label extension study. The Journal of Dermatology 50:11, pages 1459-1472.
Crossref
Tomoko Fujimoto, Takaaki Terahara, Koji Okawa, Hiroshi Inakura, Yuta Hirayama & Hiroo Yokozeki. (2023) A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study. Journal of the American Academy of Dermatology 89:1, pages 62-69.
Crossref
Mohamed El-Samahy, Adel Mouffokes, Marwa M. Badawy, Sarah Amro, Taha Fayad & Omar Ahmed Abdelwahab. (2023) Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials. Archives of Dermatological Research 315:8, pages 2215-2226.
Crossref
Ottavio Adorisio, Enrico Davoli, Emanuela Ceriati, Sonia Battaglia, Daniela Camanni & Francesco De Peppo. (2022) Effectiveness of unilateral sequential video-assisted sympathetic chain blockage for primary palmar hyperidrosis in children and adolescents. Frontiers in Pediatrics 10.
Crossref
Max J. SolishIryna SavinovaMichael J. Weinberg. (2022) A Practical Approach to the Diagnosis and Treatment of Palmar Hyperhidrosis. Plastic and Reconstructive Surgery - Global Open 10:3, pages e4172.
Crossref
Gulhima Arora, Martin Kassir, Anant Patil, Payam Sadeghi, Michael H. Gold, Maurice Adatto, Stephan Grabbe & Mohamad Goldust. (2021) Treatment of Axillary hyperhidrosis. Journal of Cosmetic Dermatology 21:1, pages 62-70.
Crossref
Michaela Gabes, Helge Knüttel & Christian J. Apfelbacher. (2021) Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review. Systematic Reviews 10:1.
Crossref
Sonia Sanajou, Gönül Şahin & Terken Baydar. (2021) Aluminium in cosmetics and personal care products. Journal of Applied Toxicology 41:11, pages 1704-1718.
Crossref
Nathan B. Morris & Ollie Jay. (2020) Aluminium salt-based antiperspirant coated prosthesis liners do not suppress local sweating during moderate intensity exercise in hot and temperate conditions. Journal of Science and Medicine in Sport 23:12, pages 1128-1133.
Crossref
Anna Campanati, Stamatios Gregoriou, Veronica Consales, Giulio Rizzetto, Ivan Bobyr, Federico Diotallevi, Emanuela Martina, George Kontochristopoulos, Eftychia Platsidaki & Annamaria Offidani. (2020) Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study. Dermatologic Therapy 33:6.
Crossref
Cai He, Lanyue Tan, Qiu Zhang, Zhenyu Chen, Yongjuan Liu & Xiangfeng Leng. (2019) Small Incision in Lower Posterior Axillary Wall Combining Multihole Drainage Technique for the Treatment of Axillary Bromhidrosis. Indian Journal of Surgery 82:2, pages 151-156.
Crossref
Monika Chabicovsky, Swantje Winkler, Michael Soeberdt, Ana Kilic, Clarissa Masur & Christoph Abels. (2019) Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicology and Applied Pharmacology 370, pages 154-169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.